PlainRecalls
FDA Devices Moderate Class II Ongoing

stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616, intended for use in a Partial Knee Arthroplasty surgical procedure

Reported: April 19, 2023 Initiated: March 10, 2023 #Z-1386-2023

Product Description

stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616, intended for use in a Partial Knee Arthroplasty surgical procedure

Reason for Recall

Certain lots of the Restoris MultiCompartmental Knee (MCK) Tibial Baseplate Trials contain product with incorrect size laser marking

Details

Recalling Firm
Howmedica Osteonics Corp.
Units Affected
102 units
Distribution
U.S., Netherlands, Japan, China, India, Korea, and Australia.
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616, intended for use in a Partial Knee Arthroplasty surgical procedure. Recalled by Howmedica Osteonics Corp.. Units affected: 102 units.
Why was this product recalled?
Certain lots of the Restoris MultiCompartmental Knee (MCK) Tibial Baseplate Trials contain product with incorrect size laser marking
Which agency issued this recall?
This recall was issued by the FDA Devices on April 19, 2023. Severity: Moderate. Recall number: Z-1386-2023.